Back to Search Start Over

Availability, affordability, and quality of essential anti‐seizure medication in Cambodia

Authors :
Hanh Dufat
Sina Ros
Farid Boumediene
Noudy Sengxeu
Chanraksmey Aon
Jeremy Jost
Samleng Chan
Voa Ratsimbazafy
Pierre-Marie Preux
Grelier, Elisabeth
Neuroépidémiologie Tropicale (NET)
CHU Limoges-Institut d'Epidémiologie Neurologique et de Neurologie Tropicale-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut Génomique, Environnement, Immunité, Santé, Thérapeutique (GEIST)
Université de Limoges (UNILIM)-Université de Limoges (UNILIM)
Cibles Thérapeutiques et conception de médicaments (CiTCoM - UMR 8038)
Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université Paris Cité (UPCité)
Service de l'Information Médicale et de l'Évaluation [CHU Limoges] (SIME)
CHU Limoges
Laboratoire de Biostatistique et d'Informatique Médicale
Université de Limoges (UNILIM)
Service de Pharmacie Centrale [CHU Limoges]
Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université de Paris (UP)
Source :
Epilepsia Open, Vol 6, Iss 3, Pp 548-558 (2021), Epilepsia Open, Epilepsia Open, 2021, ⟨10.1002/epi4.12514⟩, Epilepsia Open, The International League Against Epilepsy 2021, ⟨10.1002/epi4.12514⟩
Publication Year :
2021
Publisher :
Wiley, 2021.

Abstract

International audience; Objective: Epilepsy is a major neurological disorder that requires long-term medical treatment. Once epilepsy is diagnosed, people with epilepsy face many difficulties in accessing treatment (treatment gap). Our objective was to assess the situation regarding the availability, price, affordability, and quality of anti-seizure medication (ASM), which are major determinants of access to treatment. Method: A cross-sectional study was performed in provincial/district hospitals and private pharmacies in urban and rural areas in Cambodia. Data on ASM availability and price were obtained through drug suppliers. Affordability was estimated as the number of day wages the lowest-paid government employee must work to purchase a monthly treatment. Samples of ASM were collected, and the quality of ASM was assessed through Medicine Quality Assessment Reporting Guidelines. Results: Out of 138 outlets visited, only 72 outlets (52.2% [95% CI 43.5-60.7]) had at least one ASM available. Phenobarbital 100 mg was the most available (35.5%), followed by carbamazepine 200 mg (21.7%), phenobarbital 50 mg (11.6%), sodium valproate 500 mg (9.4%), and phenytoin 100 mg (9.4%). In provincial/district hospitals, ASM was provided free of charge. In private pharmacies, affordability for phenobarbital 50 mg and 100 mg was the best, with 0.6 and 0.5 days, respectively, compared to phenytoin 100 mg (1.8 days), and other ASM. No counterfeit ASM was found in this study. Phenytoin sample presented the worst quality (33.0%) compared to carbamazepine (27.8%), and other ASM. Significance: A lack of access to affordable and effective ASM due to low availability and poor quality of ASM was identified. Our research highlights the need for future policy efforts to ensure the quality of ASM and improve their availability. This can be achieved by involving the calculation of their annual needs for these drugs and increasing the national production of ASM.

Details

Language :
English
ISSN :
24709239
Volume :
6
Issue :
3
Database :
OpenAIRE
Journal :
Epilepsia Open
Accession number :
edsair.doi.dedup.....a1d779bf2cbe989d140f6e8102fb50fd
Full Text :
https://doi.org/10.1002/epi4.12514⟩